Celyad prices $47.3M global offering

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Commercial Banking: June 22nd Edition

Understanding Loss Given Default A Review of Three Approaches

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy

Celyad SA priced an offering of 523,913 American depositary shares at $26.28 each.

The Belgian biopharmaceutical company is also looking to sell 1,276,087 common shares at €22.29 apiece.

All in all, the company expects to raise $47.3 million in a global offering that closes May 22.

Wells Fargo Securities LLC and Bryan Garnier & Co. are acting as the joint book-running managers for the offering.

Bank Degroof Petercam NV and LifeSci Capital LLC are acting as co-managers for the offering. Kempen & Co. NV is Celyad's adviser in the offering.

The offering's underwriters can buy an additional 270,000 shares from the company.